[The importance of adrenergic beta-receptors for the cardiotoxic action of sympathomimetic amines].
D000818:Animals; D001993:Bronchodilator Agents / Q000633:toxicity*; D004837:Epinephrine / Q000633:toxicity*; D004983:Ethanolamines / Q000633:toxicity*; D006321:Heart / Q000187:drug effects*; D006331:Heart Diseases / Q000209:etiology*; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000633:toxicity*; D009921:Metaproterenol / Q000633:toxicity; D009336:Necrosis / Q000209:etiology; D009638:Norepinephrine / Q000633:toxicity*; D051381:Rats; D011984:Sensory Receptor Cells / Q000502:physiology*; D013566:Sympathomimetics / Q000633:toxicity*; D014665:Vasodilator Agents / Q000633:toxicity*
D001993:Bronchodilator Agents; D004983:Ethanolamines; D013566:Sympathomimetics; D014665:Vasodilator Agents; D009921:Metaproterenol; D007545:Isoproterenol; D009638:Norepinephrine; D004837:Epinephrine
Die Bedeutung der adrenergischen beta-Rezeptoren für die cardiotoxische Wirkung sympathicomimetischer Amine.